“稻米造血”之父即将迎来一个IPO

东四十条资本
02 Jul

将东四十条资本设为“星标⭐”,第一时间收获最新推送科创板第五套标准正式迎来重启后首家过会企业。作者丨陈美来源丨东四十条资本对于未盈利科创企业,证监会正在大力支持。2025年7月1日,武汉禾元生物科技股份有限公司(简称禾元生物)上会通过,科创板第五套标准正式迎来重启后的首家过会企业。一位投资人兴奋地表示:“这是第五套标准重启后的首家公司,且为生物医药领域,对于投资人和行业而言,意义重大,市场期待值...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10